Urologix, Inc., offers the Prostatron System, which is designed to reducethe symptoms and obstruction due to BPH by delivering a controlled doseof microwave energy to the prostate without damaging the urethra or surroundingstructures. The system delivers microwave energy to the prostate transurethrallythrough a specially designed treatment catheter that encases a tiny microwaveantenna.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.